[1]Two-year safety evaluation of a biodegradable polymer sirolimus-eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort [2]Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis. [3]Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Corners Trial and the RESOLUTE Global Clinical Trial Program [4]Bioabsorbable Drug-Eluting Stent Versus Bare Metal Stent in Iliac Artery Evaluated by Optical Coherence Tomography: An In Vivo Study in Porcine [5]Efficacy of drug-eluting balloon versus sirolimus-eluting stent for the treatment of in-stent restenosis [6]A prospective, multicenter, randomized trial comparing paclitaxel-coated balloon with Paclitaxel-eluting stent for the treatment of drug-eluting stent restenosis: 9-month angiographic and 12-month clinical Result from PEPCAD China ISR [7]Comparison of repeated drug eluting stent for treatment of early and late in-stent restenosis after drug eluting stent implantation [8]Clinical features and long-term outcomes of pediatric spinal meningiomas [9]Drug-Eluting Balloon Versus Bare-Mental Stent and Drug-Eluting Stent for De Novo Coronary Artery Disease: a Systematic Review and Meta-Analysis [10]Clinical Features and Long-Term Outcomes of Unilateral Moyamoya Disease